Tampa, FL, United States of America

Ray A Olsson


Average Co-Inventor Count = 1.6

ph-index = 6

Forward Citations = 203(Granted Patents)


Location History:

  • Odessa, FL (US) (1991 - 1994)
  • Tampa, FL (US) (1991 - 2001)

Company Filing History:


Years Active: 1991-2001

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Ray A Olsson: Innovator in Cardiac Therapeutics

Introduction

Ray A Olsson is a notable inventor based in Tampa, Florida, recognized for his contributions to the field of cardiac therapeutics. He holds a total of seven patents, showcasing his innovative approach to developing new medical compounds.

Latest Patents

Among his latest patents are significant advancements in the treatment of cardiovascular conditions. One of his notable inventions is the N-6 substituted-5′-(N-substituted carboxamide)adenosines, which serve as cardiac vasodilators and antihypertensive agents. Additionally, he has developed compounds of the formula N^6-substituted 9-methyladenines, representing a new class of adenosine receptor antagonists. These novel compounds are designed to antagonize adenosine receptors, providing potential therapeutic benefits in managing heart-related ailments.

Career Highlights

Ray A Olsson has worked with several prominent companies in the pharmaceutical and research sectors. He has been associated with Whitby Research, Inc. and Discovery Therapeutics, Inc., where he has contributed to the development of innovative medical solutions.

Collaborations

Throughout his career, Olsson has collaborated with notable professionals in the field, including Robert D Thompson. These partnerships have played a crucial role in advancing his research and patent developments.

Conclusion

Ray A Olsson's work in cardiac therapeutics exemplifies the impact of innovation in medicine. His patents and collaborations highlight his commitment to improving health outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…